Sulofenur [( N -(5-indanesulfonyl)- N -(4-chlorophenyl)urea, LY18664], the prototypic member of this class ( Figure 2C ), was evaluated in clinical trials on a variety of patients with kidney (Mahjoubi et al., 1993), ovary (OBrien et al., 1992), breast (Talbot et al., 1993), lung (Munshi et al., 1993), and stomach (Kamthan et al., 1992) cancers
Yes, its very common
With 0.5 mL, concentration is 10 mg/mL, and a 0.25 mg dose is 2.5 units
Tesamorelin and other GHRH analogs are also included in the World Anti-Doping Agency's (WADA) S2 category of prohibited peptide hormones and growth factors, making it banned for athletes in competitions that follow WADA rules
Their ease of use makes them a practical choice for consistent supplementation